Orbimed Advisors LLC Abb Vie Inc. Transaction History

Orbimed Advisors LLC

$4.24 Billion
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$133.59 - $154.65 $44.1 Million - $51 Million	330,000 New	330,000 $49.2 Million
Q3 2022 Nov 14, 2022	SELL	$134.21 - $153.93 $26.8 Million - $30.8 Million	-199,800 Reduced 24.98%	600,000 $80.5 Million
Q2 2022 Aug 15, 2022	SELL	$137.62 - $174.96 $15.9 Million - $20.3 Million	-115,800 Reduced 12.65%	799,800 $122 Million
Q1 2022 May 16, 2022	SELL	$131.98 - $163.75 $20.2 Million - $25.1 Million	-153,200 Reduced 14.33%	915,600 $148 Million
Q4 2021 Feb 14, 2022	SELL	$107.43 - $135.93 $37.8 Million - $47.8 Million	-351,800 Reduced 24.76%	1,068,800 $145 Million
Q3 2021 Nov 15, 2021	BUY	$106.4 - $120.78 $26.9 Million - $30.6 Million	253,100 Added 21.68%	1,420,600 $153 Million
Q2 2021 Aug 16, 2021	SELL	$105.21 - $117.21 $4.81 Million - $5.36 Million	-45,700 Reduced 3.77%	1,167,500 $132 Million
Q1 2021 May 17, 2021	BUY	$102.3 - $112.62 $35.9 Million - $39.5 Million	350,900 Added 40.69%	1,213,200 $131 Million
Q4 2020 Feb 16, 2021	BUY	$80.49 - $108.67 $32.1 Million - $43.3 Million	398,300 Added 85.84%	862,300 $92.4 Million
Q2 2020 Aug 14, 2020	BUY	$73.37 - $98.18 $17.2 Million - $23.1 Million	235,000 Added 102.62%	464,000 $45.6 Million
Q1 2020 May 15, 2020	BUY	$64.5 - $97.79 $14.8 Million - $22.4 Million	229,000 New	229,000 $17.4 Million
Q2 2018 Aug 14, 2018	SELL	$89.78 - $106.23 $137 Million - $162 Million	-1,527,500 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$92.01 - $123.21 $43.9 Million - $58.8 Million	476,900 Added 45.39%	1,527,500 $145 Million
Q4 2017 Feb 14, 2018	SELL	$89.56 - $98.21 $81.9 Million - $89.8 Million	-914,400 Reduced 46.53%	1,050,600 $102 Million
Q3 2017 Nov 14, 2017	BUY	$69.85 - $89.22 $137 Million - $175 Million	1,965,000	1,965,000 $175 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Orbimed Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Orbimed Advisors LLC with notifications on news.

Account